Barak Ben Arye - 28 Feb 2023 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role: General Counsel
Signature: By: /s/ Steven Robbins, Attorney in Fact for Barak Ben Arye
Issuer symbol: NVCR
Transactions as of: 28 Feb 2023
Net transactions value: +$2,273,001
Form type: 4
Filing time: 02 Mar 2023, 15:56:59 UTC
Previous filing: 10 Jan 2023
Next filing: 06 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCR	Ordinary Shares	Award	$0	+17,755	+104%	$0.000000	34,907	28 Feb 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVCR	Ordinary Shares	Award	$2,273,001	+29,531		$76.97	29,531	28 Feb 2023	Ordinary Shares	29,531	$76.97	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted share units that are scheduled to vest in equal installments on each of February 28, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates.
F2	Options to buy 29,531 ordinary shares will vest and become exercisable in equal installments on each of February 28, 2024, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates.